Kumar R, Johnson M A, Yamamoto T. "一种的合成方法" [P]. US Patent, US 11387257 B2, 2015-04-19.
发明人杨光,陈志强,何建平. "Method for the Synthesis of 2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol" [P]. 中国发明专利, 专利号 CN 116552984 A, 授权公告日 2022-02-16.
发明人李文辉,沈红梅,周伟. "A Process for Preparing High-Purity 2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol" [P]. 中国发明专利, 专利号 CN 112504256 A, 授权公告日 2021-03-22.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2020, 1360, (1), 1943-1964.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2020, 2253, (8), 3253-3267.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol Using HRMS and NMR". Anal. Chem., 2016, 859, 106-116.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2010, 799, (12), 7900-7908.